Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The aim of this trial is to verify, under controlled conditions, the reported efficacy of
human cytomegalovirus (HCMV)-specific hyperimmune globulin administration to pregnant women
suffering from primary HCMV infection for the prevention of intrauterine HCMV transmission.